Primary Reviewers: Infectious Disease Specialists, Clinical Microbiologists, Hospital Infection Control Committees, and Epidemiologists.
Abstract
This synthesis reviews clinical infectious disease literature and case reports from late 2009 and early 2011, focusing on diagnostic accuracy, pathogen transmission, and antimicrobial stewardship. Key clinical findings include the low sensitivity (40–60%) of rapid influenza diagnostic tests for H1N1, the necessity of 10-to-14-day incubation periods for CSF hardware cultures to detect Propionibacterium acnes, and the superior diagnostic yield of open biopsies (91%) over CT-guided needle biopsies (53%) in vertebral osteomyelitis.
Epidemiological highlights include the documentation of a gorilla-to-human HIV transmission strain and the persistence of viral shedding (up to 75% by PCR) in healthcare workers after the resolution of influenza-related fever. In therapeutic management, the review notes the efficacy of linezolid-carbapenem combinations for persistent MRSA bacteremia (88% success rate) and the clinical equivalence of 7-day versus longer antibiotic courses for severe, uncomplicated community-acquired pneumonia. Significant public health data underscores the success of the Veterans Affairs "MRSA Bundle," which reduced ICU-acquired MRSA infections by 62% through universal nasal surveillance and contact precautions.
Clinical Summary: Infectious Disease Literature Review (2009–2011)
02:08 Influenza Diagnostic Sensitivity: CDC evaluations of rapid influenza diagnostic tests (RIDTs) indicate sensitivity for H1N1 ranges from 40% to 60%, compared to 80% for seasonal flu. Negative RIDT results are insufficient to rule out infection in febrile patients.
03:41 H1N1 Transmission Dynamics: Hospital-based studies in Mexico reported a high transmission rate among healthcare workers (22 of 190) caring for initial H1N1 patients, primarily occurring within a 2-meter radius or via direct contact.
04:30 HIV and Bacterial Meningitis: HIV-positive patients exhibit a 19-fold higher risk for bacterial meningitis (primarily Streptococcus pneumoniae) compared to uninfected populations, particularly when CD4 counts are below 200.
05:34 Efavirenz (Sustiva) Dose Escalation: Neuropsychiatric adverse events associated with efavirenz can be mitigated using a 3-week titration schedule: 200mg/day (Week 1), 400mg/day (Week 2), then the standard 600mg/day dose.
06:56 Gorilla-Source HIV: A novel retroviral strain phylogenetically linked to gorilla simian immunodeficiency virus (SIV) was identified in a human patient, confirming gorillas as a secondary source for HIV-1.
07:53 Hepatitis B Phylogenetics: Genomic analysis of Haitian Hepatitis B (genotype A1) suggests a historical lineage originating from East Africa (the Bight of Benin) via the slave trade.
10:18 Group A Streptococcus (GAS) Isolation: Nosocomial transmission of GAS from patient to healthcare worker can result in toxic shock syndrome. Strict droplet and contact isolation for 48 hours post-antibiotic initiation is mandatory.
13:18 Plague and PPE: A fatal case of primary pneumonic plague in a wildlife biologist was attributed to aerosolization during a mountain lion necropsy performed without personal protective equipment (PPE).
14:58 MRSA Bacteremia Salvage Therapy: In cases of persistent MRSA bacteremia (7+ days), salvage therapy utilizing linezolid plus a carbapenem achieved an 88% response rate, significantly outperforming vancomycin-based combinations.
18:22 Endocarditis and Subclinical Emboli: MRI imaging indicates that 80% of patients with left-sided infective endocarditis suffer subclinical brain embolization, which is associated with a 10% increase in mortality.
19:22 Legionella Environmental Vectors: Investigations identified non-sterile ice machines as sources for pseudo-outbreaks in clinical specimens. In Japan, Legionella was found abundantly in road puddles during warm weather, suggesting potential aerosolization risks.
21:33 Brain Abscess Management: Retrospective data suggests that delayed surgical drainage of luculated cerebral collections correlates with prolonged hospitalization and poorer neurological outcomes.
22:45 Extended CSF Cultures: Shunt and hardware-related CSF cultures must be held for 10–14 days to detect fastidious organisms like Propionibacterium acnes, which often grow after the standard 3-day window.
23:48 Quinolone-Resistant Tuberculosis (TB): Outpatient fluoroquinolone exposure (>10 days) more than 60 days prior to a TB diagnosis is strongly associated with the emergence of resistant M. tuberculosis strains.
11:10 Efficacy of the VA MRSA Bundle: Implementation of universal nasal screening, contact precautions, and hand hygiene led to a 62% reduction in MRSA infections in VA ICUs and a 45% reduction in non-ICU settings.
14:10 Biopsy Yield in Osteomyelitis: In hematogenous vertebral osteomyelitis, open biopsy provides a 91% diagnostic yield compared to 53% for CT-guided needle biopsy. Pre-biopsy antibiotic exposure does not statistically decrease pathogen recovery.
15:44 Community-Acquired Pneumonia (CAP) Duration: For severe but uncomplicated CAP, 7-day antibiotic courses are as effective as longer durations regarding 30-day mortality and complication rates.
17:35 Eosinophilia and Travel Screening: Blood eosinophilia is an unreliable screening marker for asymptomatic travelers returning from helminth-endemic areas, with a positive predictive value (PPV) of only 15% for previous infections.
19:00 Zoonotic Gorilla Metapneumovirus: Documented human-to-gorilla transmission of metapneumovirus in Rwanda suggests that wild populations are susceptible to human respiratory pathogens.
23:05 Inactivated Yellow Fever Vaccine: A two-dose inactivated yellow fever vaccine regimen proved as efficacious as the live attenuated version, potentially eliminating the risk of rare, fatal viscerotropic disease.
27:19 Recurrent Wound Botulism: California health data identified 17 heroin users with multiple recurrent episodes of wound botulism, highlighting the high risk of contamination in "black tar" heroin supplies.
29:54 Environmental NDM-1: The New Delhi metallo-beta-lactamase (NDM-1) gene, conferring resistance to nearly all beta-lactams including carbapenems, has been detected in public water supplies in New Delhi, India.